Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (11.765%)
Market Cap: £15.07m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

Final Trading Statement

26 Nov 2009 07:00

RNS Number : 1058D
System C Healthcare plc
26 November 2009
 



System C Healthcare plc

Pre-Close Trading Update

System C Healthcare plc (AIM: SYS) ("System C" or "the Company"), a leading provider of information solutions and services to the health and social care sector, is pleased to provide the following trading update for the six months ending 30 November 2009, prior to entering its close period.

Revenues, profit and cash have continued to grow as forecast, and the Company is on track to meet consensus market expectations for the full year. Significant increases in revenues and profits over the same period in 2008/9 reflect both strong organic growth and the impact of the acquisitions of Liquidlogic and Bluestar.

Products

Sales and deployments of System C's flagship Medway Sigma product suite continue to progress well. Over the last six months the Company has deployed 11 Medway Sigma products, including a clinical information system at Aintree University Hospitals NHS Foundation Trust, multiple deployments of its dashboard and portal modules, and an island-wide social services system and pilot ambulance system for the Isle of Man government. A contract with NHS Connecting for Health, to develop and install clinical intelligence systems in NHS Trusts, is making good progress. The Company is now looking to benefit from the ASCC framework contract that it holds with the NHS as trusts across the South of England procure the next generation of centrally-funded computer systems.

Liquidlogic, acquired in July 2009 for a consideration of up to £14.2m, has continued to gain market share in the social care sector. One of the main drivers behind the Liquidlogic transaction was to provide integrated care solutions across the health and social care sectors, and work has already begun on a number of cross-organisational projects. 

Services

Services revenues have grown significantly in line with projections. Activity has continued to increase in the Company's stronghold area of deploying a wide range of third party systems for NHS trusts across the UK. The Company also remains heavily involved in deploying third party products from iSoft and Cerner under the National Programme for IT, with both NHS Connecting for Health and Local Service Providers as clients. 

Dr Ian Denley, CEO of System C, said: "We are continuing to benefit from our reputation for quality and delivery. This, together with the strong synergy between the products and services divisions, is driving our sales growth.

"We continue to expand and develop our product range, in line with the strategy we have set out previously, and product sales now account for approximately 50% of revenues.

We see many opportunities in both the product and services business and remain confident of reporting continuing progress through the second half of the year."

For further information please contact:

System C Healthcare plc

Tel: 01622 691616

Dr Ian Denley, Chief Executive

Andrew Coll, Finance Director

Charles Stanley Securities (Nominated Adviser)

Tel: 020 7149 6000

Russell Cook / Jen Boorer

Maitland (Financial and Corporate Communications)

Tel: 020 7379 5151

Emma Burdett/Richard Farnsworth

Notes to editors

System C Healthcare plc (www.systemc.com), specialises in the design and development of clinical patient management and business intelligence software, and provides systems implementation and consulting services to the health sector.

System C Healthcare is quoted on the AIM market of the London Stock Exchange.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKPKQFBDDQDB
Date   Source Headline
19th May 20267:00 amRNSChange of Registered Office
13th Apr 20267:00 amRNSYear End Trading Update
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
9th Feb 202610:15 amRNS-RIT Infrastructure Refresh Contract Win
3rd Feb 20264:13 pmRNSDirector/PDMR Dealing
29th Jan 20262:11 pmRNS-RContract win with the Scouts Association
22nd Jan 20269:34 amRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
9th Dec 202512:06 pmRNS-RAppointment of AI Adviser
3rd Dec 20257:00 amRNSHalf Year Results to 30 September 2025
25th Nov 20257:00 amRNSNotice of Results
16th Sep 20253:38 pmRNSResult of AGM
12th Sep 202510:51 amRNSDirector Dealing
8th Sep 202512:17 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20257:00 amRNSGrant of Options and PDMR Dealings
8th Aug 20257:00 amRNSNotice of AGM and Publication of Accounts
29th Jul 202510:17 amRNSDirector/PDMR Dealing
24th Jul 20257:00 amRNSFinal Results for the year ended 31 March 2025
14th Jul 20257:00 amRNSNotice of Results
29th Apr 20257:00 amRNSYear End Trading Update
20th Mar 202511:34 amRNS-RSysGroup Joins Rubrik's Advanced Partner Program
29th Jan 20259:17 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirector/PDMR Dealing
22nd Jan 20257:00 amRNSHolding(s) in Company
19th Dec 202412:45 pmRNSExercise of Options and Total Voting Rights
4th Dec 20244:00 pmRNSPresentation via Investor Meet Company
3rd Dec 20241:00 pmRNSDirector/PDMR Dealing
3rd Dec 20247:00 amRNSHalf Year Results to 30 September 2024
19th Nov 20247:00 amRNSAcquisition & Notice of Results
20th Sep 202411:00 amRNSResult of AGM
12th Sep 20247:00 amRNSAIM Rule 17 and Schedule 2(g) Disclosure
3rd Sep 20247:00 amRNSGrant of Options and Director/PDMR Dealings
21st Aug 20244:50 pmRNSGrant of Options and Director/PDMR Dealings
15th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
31st Jul 20247:00 amRNSFinal Results for the year ended 31 March 2024
24th Jul 20247:00 amRNSNotice of Results
28th Jun 202410:10 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSHolding(s) in Company
24th Jun 20244:12 pmRNSResult of General Meeting and Total Voting Rights
14th Jun 20247:00 amRNSResult of Retail Offer
7th Jun 20248:00 amRNSLaunch of Retail Offer
7th Jun 20247:00 amRNSResult of Oversubscribed Placing and Subscription
6th Jun 20245:11 pmRNSProposed Fundraising
3rd Jun 20247:00 amRNSBoard Changes
29th May 20247:00 amRNSStrategic Partnership
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.